Bank of America files Form 3: 27 shares of Aptevo (APVO)

Bank of America Corporation and two wholly owned subsidiaries — Bank of America N.A. and BofA Securities, Inc. — jointly filed an initial Form 3 reporting beneficial ownership in Aptevo Therapeutics Inc. (APVO).

Rhea-AI Filing Summary

Bank of America Corporation and two wholly owned subsidiaries — Bank of America N.A. and BofA Securities, Inc. — jointly filed an initial Form 3 reporting beneficial ownership in Aptevo Therapeutics Inc. (APVO). The filing shows a combined indirect holding of 27 shares of Aptevo common stock, held by the subsidiaries and attributable to the parent through ownership of those subsidiaries. The filing notes the reporting owners may have temporarily held voting and dispositive power over additional shares due to short-term stock borrowings, and clarifies the filing is not an admission of acting as a group under Section 13(d).

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BANK OF AMERICA CORP /DE/, BANK OF AMERICA NA, BOFA SECURITIES, INC.

Role 10% Owner | 10% Owner | 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 27 shares (Indirect, See Footnotes)

Footnotes (3)

1. F1. The 27 common stock shares ("Shares") reported as acquired in Table I represent Shares of APTEVO THERAPEUTICS INC.("the Issuer") beneficially owned by Bank of America N.A. ("BANA"), and BofA Securities, Inc. ("BOFAS"). BANA and BOFAS are wholly owned subsidiaries of Bank of America Corporation ("Bank of America"). The Reporting Owners may be deemed to have temporarily held voting and dispositive power over additional shares as a result of short-term stock borrowings.
2. F2. This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I ("the Securities") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS.
3. F3. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bank of America disclose about Aptevo (APVO)?

The filing reports a joint initial Form 3 disclosing an indirect beneficial ownership of 27 shares of Aptevo common stock.

Which Bank of America entities are reporting ownership?

The statement is jointly filed by Bank of America Corporation, Bank of America N.A. (BANA), and BofA Securities, Inc. (BOFAS).

What is the date of the event requiring the Form 3 filing?

The Date of Event Requiring Statement reported on the form is 09/30/2025.

Does the filing indicate control over additional shares?

Yes. The filing states the reporting owners may have temporarily held voting and dispositive power over additional shares due to short-term stock borrowings.

Does the Form 3 assert the reporters are acting as a group under Section 13(d)?

No. The filing explicitly states it should not be construed as an admission that the reporting persons are acting as a group under Section 13(d).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 01:59 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last) (First) (Middle)

BANK OF AMERICA CORPORATE CENTER

100 N TRYON ST

(Street)

CHARLOTTE NC 28255

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/30/2025

3. Issuer Name and Ticker or Trading Symbol
Aptevo Therapeutics Inc. [ APVO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)(2)(3)	27	I	See Footnotes(1)(2)(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last) (First) (Middle)

BANK OF AMERICA CORPORATE CENTER

100 N TRYON ST

(Street)

CHARLOTTE NC 28255

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BANK OF AMERICA NA

(Last) (First) (Middle)

100 NORTH TRYON STREET

(Street)

CHARLOTTE NC 28255

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BOFA SECURITIES, INC.

(Last) (First) (Middle)

150 N COLLEGE ST

NC1-028-28-04

(Street)

CHARLOTTE NC 28255

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The 27 common stock shares ("Shares") reported as acquired in Table I represent Shares of APTEVO THERAPEUTICS INC.("the Issuer") beneficially owned by Bank of America N.A. ("BANA"), and BofA Securities, Inc. ("BOFAS"). BANA and BOFAS are wholly owned subsidiaries of Bank of America Corporation ("Bank of America"). The Reporting Owners may be deemed to have temporarily held voting and dispositive power over additional shares as a result of short-term stock borrowings.

2. This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I ("the Securities") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS.

3. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

	/s/ Andres Ortiz, Authorized Signatory for Bank of America Corporation	10/03/2025
	/s/ Andres Ortiz, Authorized Signatory for Bank of America N.A.	10/03/2025
	/s/ Andres Ortiz, Authorized Signatory for BofA Securities, Inc.	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.